If you follow menopause medical professionals or perimenopause content creators who advocate for women’s health on social media, or if you happen to be living the experience yourself, you probably already know that the demand for hormone patches is currently higher than their availability.
Perhaps you’ve struggled for the last few months, contacting different pharmacies in your area to see who has your prescription available. Perhaps you’ve been tempted to cut patches in half to get your prescribed dose of estradiol to address symptoms like hot flashes, night sweats, brain fog, and sleep disruptions. Or maybe you’re unable to find patches at all, so you’ve simply dealt with symptoms for two or more months while you wait patiently for a refill.
As of October 2026, the FDA has not declared an official shortage of estradiol patches, but thousands of women across the country report trouble finding their usual product at local pharmacies. Over the last several months, the demand for estrogen patches has increased, and the companies who manufacture hormone patches simply can’t keep up with the higher demand.
Why Has Demand for Estrogen Patches Increased?
In November 2025, the FDA began removing a majority of black box warnings from estrogen therapy products. These warnings, which had been on estrogen medications for decades, specifically warned women of a potentially higher risk of breast cancer, cardiovascular disease, and probable dementia in patients using hormone therapy to address menopause symptoms. These warnings were based on what we now know are misinterpreted data from the Women’s Health Initiative (WHI) study from 2002.
More recent research critiqued the WHI studies, and discovered that, in fact, there was no significant increase in many types of breast cancer risks, cardiovascular disease, and dementia, as they originally declared. The 2002 WHI study was flawed in several ways—the age of women in the study; synthetic forms of hormones—and therefore, the results were not accurately applicable to all perimenopausal and menopausal women who wanted to use hormone therapy (i.e., estrogen patches) as a way to mitigate symptoms and help improve their quality of life.
The Estrogen Patch Surge of 2026
Conversations around menopause have become an open dialogue in recent past. This, combined with the black box warning removals, led many women to their providers looking for ways to manage midlife symptoms, and both patients and providers became more open to hormone replacement therapies. According to one study, prescriptions of estrogen patches have increased 162% over the past two years.
How Is Menopause Hormone Therapy Changing for Women?
It’s inspiring that a new generation of women are much more informed, aware, and vocal about advocating for the healthcare they deserve as they transition from childbearing years into menopause and beyond. Women’s health is a top priority for so many providers, as well.
As recent as October 15, 2026, the American College of Obstetricians & Gynecologists (ACOG) published new, expanded clinical guidance on the management of certain symptoms of menopause. Said Bruce Pier, MD, FACOG, coauthor of the new guidance:
“Hormone therapy is a really important tool we have to help with menopause symptom management. Unfortunately, misconceptions about the risks of hormone therapy have affected some clinicians’ willingness to prescribe it and some patients’ interest in using it. This new guidance importantly includes a comprehensive review of the evidence on menopausal hormone therapy to guide individualized patient counseling and shared-decision-making conversations about treatment options.”
And at the writing of this article, the President of the United States had just signed an executive order creating a Women’s Health Division at the National Institutes of Health, plus a White House Women’s Health Task Force, “aiming to close research gaps and modernize care for women.”
While all of this progress is wonderful news for women in perimenopause and younger generations who will face midlife health challenges, those still struggling to get their estrogen patch prescription need symptom relief now. Even as we make progress to raise awareness and prioritize equity for women’s healthcare, the vast majority of women and providers are still unaware that compounded hormone therapies may be a viable option.
What Estrogen Patch Alternatives May Address Menopause Symptoms?
Compounded hormone creams may be an ideal approach for addressing menopause symptoms for many women. So, if you can’t get the patch, you may want to consider compounded estradiol cream (the most common form of estrogen), or even biest (pronounced “by-est”) for a combination of estradiol (E2) and estriol (E3), two of the body’s primary estrogens.
A provider experienced in hormone therapy can help decide whether a compounded prescription makes sense for your symptoms and needs. For example, if your provider determines that a specific strength of estradiol not commercially available is ideal for you, or you have a sensitivity to certain ingredients, a compounded hormone cream (made without that particular ingredient in your specific strength) may be a good fit.
For many women, the peace of mind knowing that a compounded form of estradiol or biest hormone cream is readily available and personalized for their individual needs, is enough to make them consider this alternative to hormone patches. Ultimately, each woman experiences menopause in her own unique way, so the right therapy is one she and her provider decide on together that works best with her individual needs and lifestyle.
If you’re interested in learning more about hormone therapy for women, we invite you to explore Belmar Pharmacy’s bioidentical hormone replacement therapy (BHRT) options, and have a conversation with your provider.
References:
Trump launches women’s health initiative at National Institutes of Health: https://www.nbcnews.com/politics/trump-administration/trump-melania-womens-health-nih-rcna604387
Menopause at a turning point: RWD matters more than ever: https://blog.healthverity.com/menopause-at-a-turning-point-rwd-matters-more-than-ever
A critique of Women’s Health Initiative Studies (2002-2006): https://pmc.ncbi.nlm.nih.gov/articles/PMC1630688/
The Women’s Health Initiative Randomized Trials and Clinical Practice: A Review
https://jamanetwork.com/journals/jama/article-abstract/2818206
New guidelines back use of hormone therapy for menopause, perimenopause symptoms. Here’s what to know. https://www.cbsnews.com/news/menopause-perimenopause-hormone-replacement-therapy-guidelines-acog/?utm_source=join1440&utm_medium=email&utm_placement=newsletter&user_id=6866e3a74018c28f57090f0e
FDA Update on Estradiol Transdermal Patch Availability: https://www.fda.gov/drugs/drug-alerts-and-statements/fda-update-estradiol-transdermal-patch-availability
Estrogen patches are hard to find, and it may not be resolved any time soon: https://www.cnbc.com/2026/06/26/estrogen-patches-are-in-short-supply-as-women-seek-menopause-support.html
